| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,881 |
5,871 |
$332K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,127 |
2,739 |
$235K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,842 |
4,920 |
$232K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,467 |
2,136 |
$191K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,209 |
1,869 |
$168K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,827 |
1,593 |
$132K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
978 |
792 |
$80K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,459 |
2,158 |
$73K |
| 92552 |
|
3,474 |
2,892 |
$71K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,117 |
4,286 |
$38K |
| 96127 |
|
6,283 |
3,453 |
$27K |
| 99401 |
|
951 |
600 |
$20K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,236 |
1,162 |
$19K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,603 |
744 |
$18K |
| 99173 |
|
3,384 |
2,836 |
$16K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
439 |
374 |
$16K |
| 96161 |
|
1,197 |
979 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,307 |
1,233 |
$15K |
| 99177 |
|
1,763 |
1,500 |
$13K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
391 |
337 |
$12K |
| 81003 |
|
3,838 |
3,185 |
$8K |
| 36416 |
|
5,163 |
4,314 |
$7K |
| 83655 |
|
529 |
410 |
$6K |
| 1159F |
|
5,674 |
4,693 |
$6K |
| 1160F |
|
5,674 |
4,692 |
$6K |
| 3008F |
|
4,898 |
4,126 |
$6K |
| 96160 |
|
461 |
348 |
$5K |
| 80061 |
Lipid panel |
366 |
298 |
$5K |
| 90461 |
|
2,666 |
2,255 |
$4K |
| 90670 |
|
1,354 |
1,231 |
$3K |
| 90686 |
|
3,900 |
3,399 |
$3K |
| 90716 |
|
184 |
157 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
37 |
30 |
$1K |
| 90707 |
|
184 |
156 |
$1K |
| 0072A |
|
34 |
33 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13 |
13 |
$1K |
| 90651 |
|
36 |
27 |
$867.66 |
| 87807 |
|
91 |
78 |
$830.85 |
| 97802 |
|
61 |
51 |
$788.08 |
| 0071A |
|
12 |
12 |
$480.00 |
| 94760 |
|
1,823 |
1,519 |
$470.23 |
| 90734 |
|
72 |
53 |
$442.95 |
| 90680 |
|
404 |
377 |
$415.28 |
| 90723 |
|
177 |
164 |
$411.78 |
| 90633 |
|
450 |
383 |
$392.06 |
| 90648 |
|
750 |
684 |
$251.86 |
| 90681 |
|
140 |
128 |
$0.00 |
| 90685 |
|
102 |
99 |
$0.00 |
| 3048F |
|
168 |
127 |
$0.00 |
| 90698 |
|
121 |
112 |
$0.00 |
| 91307 |
|
97 |
86 |
$0.00 |